Biomarkers in COPD
COPD is lagging in the precision medicine race. The term COPD was designed to be an umbrella term, which is intentionally heterogeneous. To help understand the physiology of COPD and better treat our patients, researchers have evaluated many biomarkers in COPD. There are now robust validated biomark...
Main Authors: | Ramakrishnan, S, Bafadhel, M |
---|---|
Other Authors: | Janes, SM |
Format: | Book section |
Language: | English |
Published: |
Elsevier
2021
|
Similar Items
-
Is it time to give up on "self-management" of COPD exacerbations?
by: Ramakrishnan, S, et al.
Published: (2020) -
Eosinophils in COPD: just another biomarker?
by: Bafadhel, M, et al.
Published: (2017) -
Neutrophil elastase as a biomarker for bacterial infection in COPD
by: Thulborn, S, et al.
Published: (2019) -
Symptomatic COPD: is it time for triple therapy?
by: Bafadhel, M
Published: (2018) -
Neutrophil elastase as a biomarker for bacterial infection in COPD
by: Samantha J. Thulborn, et al.
Published: (2019-07-01)